Inj. Natrii Chlorati Polpharma

Sodium chloride, the active ingredient in Inj. Natrii Chlorati Polpharma, is an electrolyte solution presented as an injection for intravenous use. It provides sodium and chloride ions to restore extracellular fluid volume and correct electrolyte imbalances in patients who require fluid replacement, such as those with hyponatremia, postoperative fluid loss, or severe dehydration.

GNH USA supplies Inj. Natrii Chlorati Polpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Inj. Natrii Chlorati Polpharma is an intravenous electrolyte solution used in clinical situations that require fluid and electrolyte management.

- Fluid replacement: restores intravascular volume in patients with blood loss, dehydration or surgical fluid loss. - Electrolyte replenishment: supplies sodium and chloride to correct deficits during illness or treatment. - Treatment of hyponatremia: raises serum sodium concentration in patients with low sodium levels. - Diluent for intravenous drug administration: serves as a compatible carrier for reconstituting and delivering other IV medications.

Adverse reactions to sodium chloride injection may vary in frequency and severity.

Common Side Effects: - Injection site pain or erythema. - Mild hypernatremia leading to thirst. - Edema or peripheral swelling. - Headache. - Nausea.

Serious or Rare Side Effects: - Severe hypernatremia with neurological symptoms. - Anaphylactic or severe allergic reaction. - Volume overload causing pulmonary edema. - Cardiac arrhythmia due to electrolyte imbalance. - Acute renal failure in susceptible patients.

When using Inj. Natrii Chlorati Polpharma, clinicians should observe several safety considerations.

- Assess fluid status: evaluate volume needs before infusion. - Monitor serum electrolytes: check sodium and chloride levels regularly. - Adjust infusion rate in cardiac or renal disease: avoid rapid administration. - Use caution in neonates and pediatric patients: dose and rate must be individualized. - Avoid rapid infusion in patients with heart failure: risk of volume overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Sodium chloride injection can influence or be influenced by other therapies.

Major Interactions (Avoid): - Concomitant hypertonic saline solutions: may cause severe hypernatremia. - Potassium chloride infusions administered simultaneously: risk of electrolyte imbalance. - Loop diuretics given in high doses: can exacerbate sodium loss.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may affect renal handling of sodium. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): can alter renal perfusion. - Corticosteroids: may increase sodium retention and fluid retention.